Skip to main content
. 2020 Jun 18;5(2):159–176. doi: 10.1136/svn-2020-000378

Figure 2.

Figure 2

Intravenous recombinant tissue plasminogen activator (IV rt-PA) administration in patients with ischaemic stroke within 4.5 hours of onset.